Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    Menu

    Crofelemer

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,823Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jaguar Health Meets FDA To Advance Crofelemer Trial
    Jaguar Health Meets FDA To Advance Crofelemer Trial

    06 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-06/jaguar-health-completes-meeting-with-fda-for-advice-on-development-pathways-to-advance-ongoing-crofe

    PHARMIWEB
    06 Oct 2025
    Share Share
    FDA Grants Expanded Access for Jaguar’s Crofelemer in MVID
    FDA Grants Expanded Access for Jaguar’s Crofelemer in MVID

    30 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-30/fda-authorized-expanded-access-programs-utilizing-jaguar-healths-novel-crofelemer-powder-for-oral-s

    PHARMAWEB
    30 Sep 2025
    Share Share
    Jaguar Health Gets $250k FDA Grant For Canalevia Trial In Dogs
    Jaguar Health Gets $250k FDA Grant For Canalevia Trial In Dogs

    25 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-25/jaguar-health-receives-notice-of-250-000-fda-grant-to-fund-confirmatory-trial-to-support-fda-approv

    PHARMAWEB
    25 Sep 2025
    Share Share
    Jaguar Health Seeks FDA Orphan Drug Designation for Crofelemer
    Jaguar Health Seeks FDA Orphan Drug Designation for Crofelemer

    24 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-24/jaguar-health-submits-orphan-drug-designation-application-to-fda-for-crofelemer-for-cancer-therapy-r

    PHARMAWEB
    24 Sep 2025
    Share Share
    Jaguar Health Aims to Expand Canalevia's Use at Health Summit
    Jaguar Health Aims to Expand Canalevia's Use at Health Summit

    21 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-21/jaguar-health-participating-in-august-25-26-animal-health-summit-with-goal-of-securing-collaboration

    PHARMAWEB
    21 Aug 2025
    Share Share
    Jaguar's Proposals Approved at 2025 Annual Stockholders Meeting
    Jaguar's Proposals Approved at 2025 Annual Stockholders Meeting

    19 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-19/jaguar-health-reports-approval-of-all-proposals-at-august-2025-annual-meeting-of-stockholders

    PHARMAWEB
    19 Aug 2025
    Share Share